Arysta LifeScience Corp. has signed a global licensing agreement with French-based Delbon for Delsol, a soil biostimulant containing the microorganism Pseudomonas putida “fluorescent.” The agreement also gives Arysta LifeScience first refusal right to other new biostimulant technology developed by Delbon and its scientific partners.

Delsol is a proprietary product that was developed by Delbon and CIRAD-Montpellier in France. Delsol allows farmers to grow crops in difficult soil conditions by preserving beneficial microbial soil activity and optimizing the soil’s nutritional capacity, according to the two companies.

Arysta LifeScience announced it intends to focus first on development of Delsol in the fruit and vegetable market. Product evaluation of Delsol will start in early 2013, and the first sales are expected in 2014, according to Arysta.

“Microbial soil balance has often been neglected by modern agriculture,” said Benoit Genot, head of marketing, Global Biostimulants and Value-added Nutrients, Arysta LifeScience. “Biostimulation though soil microorganisms is now gaining momentum. The total biostimulant and value-added nutrient market is $2.5 billion, with average growth at 8 percent per annum in the Arysta LifeScience focused area. Delsol is presented in a liquid form so that it can be used easily with farmer’s existing sprayers and irrigation systems, making the product an ideal partner for our liquid humic acid products, such as Humitron.”

François Deleuze, CEO of Delbon added, “Our companies complement each other well. “Delbon has strong production assets and is looking to invest in new production capacity as product demand will increase. Arysta LifeScience is focused on field development, marketing and distribution of the product in key countries. This agreement is a good fit to maximize the market potential for Delsol.”